Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FFW8Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,729
Award facts
- Contract value 100% obligated
- $7,728.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $7,728.90 delivery order to Amerisourcebergen Drug Corp on July 17, 2026, for Boostrix TDAP vaccine in 0.5 mL syringe configuration.
Place of performance is Conshohocken, Pennsylvania. Ultimate completion date is July 20, 2026. The order carries firm fixed-price pricing and no set-aside.
Quick answers
Who was awarded contract SPE2DR26FFW8Z?
SPE2DR26FFW8Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2026.
How much is contract SPE2DR26FFW8Z worth?
The government has obligated $7,729 on SPE2DR26FFW8Z.
Is contract SPE2DR26FFW8Z an order under another contract?
Yes. SPE2DR26FFW8Z is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFW8Z competed?
The extent of competition for SPE2DR26FFW8Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award